Evidence map›Paper›PMID 31045419›Full record

Trial reportHealth psychology : official journal of the Division of Health Psychology, American Psychological Association2019

Use of the PROMIS® Depression scale and the Beck Depression Inventory in patients with heart failure.

Kenneth E Freedland, Brian C Steinmeyer, Robert M Carney, Eugene H Rubin, Michael W Rich

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kenneth E FreedlandDepartment of Psychiatry, Washington University School of Medicine in St. Louis.ORCID 0000-0002-3118-9913
Brian C SteinmeyerDepartment of Psychiatry, Washington University School of Medicine in St. Louis.
Robert M CarneyDepartment of Psychiatry, Washington University School of Medicine in St. Louis.
Eugene H RubinDepartment of Psychiatry, Washington University School of Medicine in St. Louis.
Michael W RichDepartment of Medicine, Washington University School of Medicine in St. Louis.
Washington University in St. Louis · US

Funding

Fatigue, Anhedonia and Cardiac Prognostic Markers in Depressed Patients with Coronary Heart DiseaseR01HL147862 · NHLBI · WASHINGTON UNIVERSITY · PI FREEDLAND, KENNETH E · 2020 to 2024
$3.6M
TREATMENT OF FUNCTIONAL IMPAIRMENT IN PATIENTS WITH HEART FAILURE AND COMORBID DER01HL091918 · NHLBI · WASHINGTON UNIVERSITY · PI FREEDLAND, KENNETH E · 2009 to 2012
$2.9M
NHLBI NIH HHSNHLBI NIH HHS R01 HL091918NHLBI NIH HHS R01 HL147862
6 · The paper itself

Abstract

objectiveThis study evaluated agreement between the Patient-Reported Outcomes Measurement Information System® (PROMIS®) Depression scale and the Beck Depression Inventory (BDI-II) in patients with heart failure and comorbid major depression.

methodThe BDI-II and the computerized adaptive test version of the PROMIS® Depression scale were administered at baseline to 158 participants in a randomized controlled trial of cognitive behavior therapy for major depression in patients with heart failure. A crosswalk table (Choi, Schalet, Cook, & Cella, 2014) was used to transform the PROMIS® scores into "linked" BDI-II equivalent scores. Bland-Altman plots, histograms, and scatterplots were used to visualize the agreement between these scores at baseline and 6 months, and intraclass correlation coefficients (ICCs) were calculated for each occasion to quantify the agreement. Treatment effects and change scores were also examined.

resultsThe measures agreed moderately at baseline (ICC = 0.52, p < .0001) and strongly at 6 months (ICC = 0.77, p < .0001), but on average, the linked and observed BDI-II scores differed by 3.1 points at baseline (p < .0001) and -0.17 points at 6 months (p = .78). The discrepancies were considerably larger in many individual cases on both occasions.

conclusionsThe PROMIS® Depression scale is likely to play an important role in research on depression in patients with heart failure, but for now, it should be used in addition to rather than instead of the BDI-II in studies in which the BDI-II would ordinarily be used. Additional research is needed to evaluate the validity and utility of the PROMIS® Depression scale in patients with heart failure. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Indexed as

Patient Reported Outcome MeasuresComorbidityDepressionFemaleHeart FailureHumansMaleMiddle Aged

Identifiers

PMID31045419
PMCPMC6499487
OpenAlexW2942817308

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.